Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
3
×
national top stories
boulder/denver blog main
boulder/denver top stories
depression
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
postpartum depression
raleigh-durham blog main
raleigh-durham top stories
sage therapeutics
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
study
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acc
acquisition
activist investor
aducanumab
alzheimer's failure
american college of cardiology
amyloid
andreas grauer
antidepressant
What
depression
3
×
medical
3
×
drug
postpartum
sage
adu
approval
approved
beats
bids
bio
biogen
brexanalone
cancer
centers
complicated
cut
dire
event
fda
genetic
good
group
guesswork
guide
heart
help
helps
hits
hour
infusion
major
making
mark
medicine
need
new
news
people
phase
Language
Current search:
depression
×
medical
×
" national blog main "
×
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
@xconomy.com
5 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?